Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations ); and in continuation to our letter bearing reference no: WOCK/SEC/SE/2025-26/065 dated 4th February, 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e.10th February, 2026, inter-alia, has approved the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2025.
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts more than Nifty Smallcap 250 and 1.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Wockhardt reported strong Q3 FY26 results, with standalone revenue rising about 32% year-on-year to Rs 430 crore and a net profit of Rs 28 crore versus a loss of Rs 22 crore in the same quarter last year. Consolidated Q3 revenue grew around 23% YoY to Rs 888 crore, with profit after tax at Rs 61 crore against Rs 20 crore a year ago. For the nine-month period, standalone profit turned around sharply to Rs 150 crore from a loss of Rs 52 crore in the prior year, reflecting both revenue growth and improved margins. The nine-month consolidated numbers, however, include a one-time exceptional charge of Rs 107 crore — mainly Rs 97 crore from deconsolidating two US subsidiaries (Morton Grove Pharmaceuticals and Wockhardt USA LLC) after the company filed for Chapter 7 bankruptcy to exit the loss-making US generic pharma business — plus Rs 10 crore for the new Labour Codes. The auditor's limited review report was clean with no qualifications.
Strong YoY revenue growth and a clear return to profitability are positive for shareholders, suggesting improved core operations. The one-time US exit charge is a strategic reset that should clean up the portfolio and support better future margins, though the stock may react to the headline Rs 107 crore exceptional drag in the nine-month numbers.